Impact of intensity-modulated proton therapy in reducing radiation-induced lymphopenia in glioma patients.
Anindita DasJacinthlyn SylviaGanapathy KrishnanPankaj Kumar PandaPreethi SubramanyamRoopesh KumarRajendran AdhithyanSushama PatilDayananda SharmaRakesh JalaliPublished in: Neuro-oncology advances (2024)
Proton therapy seems to have a superior sparing of normal brain to moderate dose radiation than photon-based RT and reduces the incidence of lymphopenia. Glioma patients with lymphopenia possibly have worse outcomes than the ones with maintained lymphocyte counts.
Keyphrases
- radiation induced
- end stage renal disease
- radiation therapy
- newly diagnosed
- chronic kidney disease
- peripheral blood
- risk factors
- peritoneal dialysis
- prognostic factors
- high intensity
- resting state
- multiple sclerosis
- adipose tissue
- metabolic syndrome
- patient reported outcomes
- blood brain barrier
- weight loss
- functional connectivity
- subarachnoid hemorrhage
- patient reported
- brain injury
- single molecule